BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 18064414)

  • 1. Presynaptic neurotoxins with enzymatic activities.
    Rossetto O; Montecucco C
    Handb Exp Pharmacol; 2008; (184):129-70. PubMed ID: 18064414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Different mechanisms of inhibition of nerve terminals by botulinum and snake presynaptic neurotoxins.
    Montecucco C; Rossetto O; Caccin P; Rigoni M; Carli L; Morbiato L; Muraro L; Paoli M
    Toxicon; 2009 Oct; 54(5):561-4. PubMed ID: 19111566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of the heterotrimeric presynaptic phospholipase A(2) neurotoxin complex from the venom of the common death adder (Acanthophis antarcticus).
    Blacklow B; Escoubas P; Nicholson GM
    Biochem Pharmacol; 2010 Jul; 80(2):277-87. PubMed ID: 20361942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro neuromuscular activity of snake venoms.
    Hodgson WC; Wickramaratna JC
    Clin Exp Pharmacol Physiol; 2002 Sep; 29(9):807-14. PubMed ID: 12165047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presynaptic snake beta-neurotoxins produce tetanic fade and endplate potential run-down during neuromuscular blockade in mouse diaphragm.
    Wilson HI; Nicholson GM
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):626-34. PubMed ID: 9402043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of presynaptic polypeptide neurotoxins from tiger snake venom (notechis-II-5 and notexin) on frog neuromuscular junction.
    Magazanik LG; Slavnova TI
    Physiol Bohemoslov; 1978; 27(5):421-9. PubMed ID: 32567
    [No Abstract]   [Full Text] [Related]  

  • 7. Understanding the molecular mechanism underlying the presynaptic toxicity of secreted phospholipases A2.
    Pungercar J; Krizaj I
    Toxicon; 2007 Dec; 50(7):871-92. PubMed ID: 17905401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different mechanism of blockade of neuroexocytosis by presynaptic neurotoxins.
    Rossetto O; Rigoni M; Montecucco C
    Toxicol Lett; 2004 Apr; 149(1-3):91-101. PubMed ID: 15093253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of transmitter release by neurotoxins from snake venoms.
    Harvey AL; Anderson AJ; Karlsson E
    J Physiol (Paris); 1984; 79(4):222-7. PubMed ID: 6152291
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Presence of presynaptic neurotoxin complexes in the venoms of Australo-Papuan death adders (Acanthophis spp.).
    Blacklow B; Konstantakopoulos N; Hodgson WC; Nicholson GM
    Toxicon; 2010 Jun; 55(6):1171-80. PubMed ID: 20064542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Synapse and neurotoxins].
    Kawai N; Miwa A
    Tanpakushitsu Kakusan Koso; 1984 Nov; 29(12 Suppl):1232-9. PubMed ID: 6396726
    [No Abstract]   [Full Text] [Related]  

  • 12. The basic science of botulinum toxin.
    Lam SM
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):431-8. PubMed ID: 15062246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysport: pharmacological properties and factors that influence toxin action.
    Pickett A
    Toxicon; 2009 Oct; 54(5):683-9. PubMed ID: 19332087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phospholipase A2 activity and substrate specificity of snake venom presynaptic toxins.
    Napias C; Heilbronn E
    Biochemistry; 1980 Mar; 19(6):1146-51. PubMed ID: 7370229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Botulinum toxin type A and cholinergic system].
    Bach-Rojecky L; Relja M; Filipović B; Lacković Z
    Lijec Vjesn; 2007 Dec; 129(12):407-14. PubMed ID: 18383744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanisms of action of botulinum toxins and neurotoxins].
    Poulain B; Lonchamp E; Jover E; Popoff MR; Molgó J
    Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S73-6. PubMed ID: 19576489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Snake venoms and the neuromuscular junction.
    Lewis RL; Gutmann L
    Semin Neurol; 2004 Jun; 24(2):175-9. PubMed ID: 15257514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of vacuolar adenosine triphosphatase antagonizes the effects of clostridial neurotoxins but not phospholipase A2 neurotoxins.
    Simpson LL; Coffield JA; Bakry N
    J Pharmacol Exp Ther; 1994 Apr; 269(1):256-62. PubMed ID: 8169833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Degeneration and regeneration of murine skeletal neuromuscular junctions after intramuscular injection with a sublethal dose of Clostridium sordellii lethal toxin.
    Barbier J; Popoff MR; Molgó J
    Infect Immun; 2004 Jun; 72(6):3120-8. PubMed ID: 15155613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuromuscular activity of BaTX, a presynaptic basic PLA2 isolated from Bothrops alternatus snake venom.
    Ponce-Soto LA; Barros JC; Marangoni S; Hernandez S; Dal Belo CA; Corrado AP; Hyslop S; Rodrigues-Simioni L
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 Aug; 150(2):291-7. PubMed ID: 19463969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.